Andreas Halvorsen - Viking Global Investors
Holding/activity history for Newamsterdam Pharma Co Nv (NAMS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 4,203,567 | 0.38 | $32.01 | $134,556,180 | SEC | ||
| 2025 Q4 | 4,203,567 | 0.39 | Reduce 35.09% | 0.17 | $35.08 | $147,461,130 | SEC |
| 2025 Q3 | 6,475,534 | 0.48 | Reduce 7.21% | 0.03 | $28.44 | $184,164,187 | SEC |
| 2025 Q2 | 6,978,534 | 0.37 | $18.11 | $126,381,251 | SEC | ||
| 2025 Q1 | 6,978,534 | 0.45 | $20.47 | $142,850,591 | SEC | ||
| 2024 Q4 | 6,978,534 | 0.58 | Reduce 13.04% | 0.06 | $25.70 | $179,348,324 | SEC |
| 2024 Q3 | 8,024,565 | 0.49 | $16.60 | $133,207,779 | SEC | ||
| 2024 Q2 | 8,024,565 | 0.59 | $19.21 | $154,151,894 | SEC | ||
| 2024 Q1 | 8,024,565 | 0.71 | $23.65 | $189,780,962 | SEC | ||
| 2023 Q4 | 8,024,565 | 0.33 | $11.17 | $89,634,391 | SEC | ||
| 2023 Q3 | 8,024,565 | 0.30 | Add 22.99% | 0.06 | $9.25 | $74,227,226 | SEC |
| 2023 Q2 | 6,524,565 | 0.32 | Add 66.62% | 0.13 | $11.89 | $77,577,078 | SEC |
| 2023 Q1 | 3,915,870 | 0.25 | Add 4.32% | 0.01 | $13.44 | $52,629,293 | SEC |
| 2022 Q4 | 3,753,828 | 0.20 | Buy | 0.20 | $10.52 | $39,490,271 | SEC |